Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Effector Therapeutics Inc (EFTR)

Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Effector Therapeutics Inc 142 North Cedros Avenue Suite B Solana Beach CA 92075 USA

effector.com P: 858-925-8215

Description:

eFFECTOR Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as STRIs. eFFECTOR Therapeutics Inc., formerly known as Locust Walk Acquisition Corp., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 7,153
Enterprise Value, $K 11,663
Shares Outstanding, K 3,687
Annual Sales, $ 0 K
Annual Net Income, $ -35,810 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,130 K
EBIT, $ -33,860 K
EBITDA, $ -34,220 K
60-Month Beta 0.52
% of Insider Shareholders 8.40%
% of Institutional Shareholders 57.67%
Float, K 3,378
% Float 91.60%
Short Volume Ratio 0.60

Growth:

1-Year Return -81.23%
3-Year Return -99.21%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.42 on 03/25/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -16.92
EPS Growth vs. Prev Qtr -5.23%
EPS Growth vs. Prev Year 37.82%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 01/12/24

EFTR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -160.00%
Profit Margin % 0.00%
Debt/Equity -3.34
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.95
Interest Coverage -11.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar